Parafibromin is a nuclear protein with a tumour suppressor role in the development of non-hereditary and hereditary parathyroid carcinomas, and the hyperparathyroidism-jaw tumour (HPT-JT) syndrome, which is associated with renal and uterine tumours. Nuclear localization signal(s), (NLS(s)), of the 61 kDa parafibromin remain to be defined. Utilization of computer-prediction programmes, identified five NLSs (three bipartite (BP) and two monopartite (MP)). To investigate their functionality, wild-type (WT) and mutant parafibromin constructs tagged with enhanced green fluorescent protein or cMyc were transiently expressed in COS-7 cells, or human embryonic kidney 293 (HEK293) cells, and their subcellular locations determined by confocal fluorescence microscopy. Western blot analyses of nuclear and cytoplasmic fractions from the transfected cells were also performed. WT parafibromin localized to the nucleus and deletions or mutations of the three predicted BP and one of the predicted MP NLSs did not affect this localization. In contrast, deletions or mutations of a MP NLS, at residues 136-139, resulted in loss of nuclear localization. Furthermore, the critical basic residues, KKXR, of this MP NLS were found to be evolutionarily conserved, and over 60% of all parafibromin mutations lead to a loss of this NLS. Thus, an important functional domain of parafibromin, consisting of an evolutionarily conserved MP NLS, has been identified.
Introduction
Mutations of the gene encoding parafibromin, a 531 amino-acid protein, are associated with hereditary and non-hereditary forms of parathyroid carcinomas, and the hyperparathyroidism-jaw tumour (HPT-JT) syndrome, which is characterized by the combined occurrence of parathyroid tumours and ossifying fibromas of the jaw (Cavaco et al., 2001; Carpten et al., 2002; Howell et al., 2003; Shattuck et al., 2003) . In addition, some patients with the HPT-JT syndrome may also develop uterine tumours and renal abnormalities, which include Wilms' tumours, hamartomas and polycystic disease (Szabo et al., 1995; Teh et al., 1996; Haven et al., 2000; Cavaco et al., 2001; Bradley et al., 2005) . Other tumours, including Hurthle cell thyroid adenomas, pancreatic adenocarcinomas and testicular mixed germ cell tumours have also been reported in some patients with HPT-JT (Haven et al., 2000; Bradley et al., 2005) . Loss of heterozygosity of the gene causing HPT-JT, which is referred to as HRPT2 and is located on chromosome 1q31.2, has been observed in HPT-JTassociated tumours, thereby indicating that HRPT2 is likely to be a tumour suppressor (Teh et al., 1996; Haven et al., 2000) . A tumour suppressor role for HRPT2 is further supported by reports that the majority of HRPT2 mutations are predicted to result in a functional loss of parafibromin, and that some HPT-JT tumours harbour both germline and somatic mutations (Howell et al., 2003; Shattuck et al., 2003; Bradley et al., 2006) , which are consistent with Knudson's 'two-hit' hypothesis (Knudson, 1971 ). The HRPT2 gene, which consists of 17 exons and is ubiquitously expressed, encodes an evolutionarily conserved 531 amino-acid protein, parafibromin (Carpten et al., 2002) . The B200 amino acids of the C-terminal segment of parafibromin have B27% sequence identity with yeast Cdc73p which is a component of the yeast Paf1 protein complex that interacts with RNA polymerase II, and studies have shown that human homologues of the yeast Paf1 complex are associated with parafibromin. (RozenblattRosen et al., 2005; Yart et al., 2005) . Thus, as part of this protein complex, parafibromin may regulate posttranscriptional events and histone modification. In keeping with such roles parafibromin has been reported to be a nuclear protein by two studies (Tan et al., 2004; Rozenblatt-Rosen et al., 2005) , although one other study has reported that parafibromin may also be in the cytoplasm (Woodard et al., 2004) .
Nuclear proteins need to be imported from the cytoplasm to the nucleus, and this translocation across the nuclear envelope is facilitated by a soluble heterodimeric receptor comprising importin a and importin b (Hodel et al., 2001; Fontes et al., 2003) . This process depends on the recognition, by importins a and b1, of clusters of basic amino acids, which are referred to as nuclear localization signals (NLSs), in the protein (Nakielny and Dreyfuss, 1999; Quadrini and Bieker, 2002) . There are two main classes of NLSs referred to as monopartite (MP) and bipartite (BP) (Hodel et al., 2001) . The MP NLS is characterized by a single cluster of Bsix basic amino acids in which Bfour residues are positively charged, that is, arginine (R) or lysine (K): The characteristic motif for a MP NLS is defined as K(K/R)X(K/R), where X is any residue, and the prototype of this is the simian virus 40 large T antigen with its sequence PKKKRKV (Krauer et al., 2004) . The BP NLS is characterized by two clusters of 2-3 positively charged basic amino acids that are separated by a 9-12 amino-acid linker region, which contains a few proline residues (Cokol et al., 2000; Quadrini and Bieker, 2002) . However, a few proteins have unusual NLSs, which resemble neither canonical signal and they lack clusters of arginine or lysine residues (Cokol et al., 2000; Krauer et al., 2004) . The NLSs for parafibromin, which is a nuclear protein of 61 kDa, need to be defined and we embarked on determining these, together with the subcellular localization of parafibromin and its mutant forms. In the course of these studies, one study reported that parafibromin contains a functional BP NLS (Hahn and Marsh, 2005) . However, our analysis of the parafibromin peptide sequence reveals that it contains five putative NLSs, three BP and two MP ( Figure 1 ) and that only one of these is evolutionarily conserved and functions as a MP NLS.
Results
Protein domain prediction programmes reveal that parafibromin contains five putative NLSs Database analysis of the 531 amino-acid sequence of human parafibromin utilizing the protein domain prediction programmes (PROSITE, PREDICT NLS and PSORT II) indicated the presence of five putative NLSs (three BPs and two MPs) (Figure 1 ). The three BP NLSs, BP-1, -2 and -3, comprised amino acids 76-92, 125-139, and 393-409, respectively. The two MP NLSs, MP-1 and -2, comprised amino acids 136-139 and 388-394, respectively. NLS BP-2 encompassed MP-1, whereas NLS MP-2 and BP-3 were overlapping ( Figure 1a) . The peptide sequences of these five NLSs (Figure 1b) conformed to the optimal sequences required for the respective MP and BP NLSs. An analysis of the parafibromin peptide sequences of Homo sapiens, Mus musculus, Rattus norvegicus, Xenopus tropicalis, Danio rerio, Drosophila melanogaster and Caenorhabditis elegans revealed that only the motif of KKXR, of MP-1 was evolutionarily conserved (Figure 1c ). This suggested that MP-1 might be the functional NLS of parafibromin. However, it is important to note that not all experimentally known NLSs contain these characteristic motifs and that non-nuclear proteins may also contain these motifs (Hodel et al., 2001) . Thus, such NLS motifs identified by the use of protein domain prediction programmes need to be investigated in cellular models to demonstrate their functional significance.
Nuclear localization of parafibromin is due to a functional MP NLS at amino-acid residues 136-139 In order to assess the functional significance of the five NLS motifs of parafibromin, we first engineered N-terminal enhanced green fluorescent protein (EGFP) or cMyc-tagged full-length and partial-length (PL) parafibromin constructs ( Figure 1a ) that lacked one or two of the NLSs and determined their effects on the nuclear localization of the protein in COS-7 ( Figure 2 ) and human embryonic kidney (HEK)293 cells by use of confocal fluorescence microscopy. We next engineered mutations within these motifs and similarly assessed their effects on nuclear localization of the protein (Figures 3-5) . Fifty transfected cells were independently examined by two of the authors (KJB and NYL) using fluorescence microscopy and the average of the two counts taken (Table 1) . Wild-type (WT) parafibromin tagged with EGFP or cMyc showed specific localization to the nucleus (Figures 2 and 5) , whereas EGFP or cMyc alone was diffusely distributed in both the cytoplasm and nucleus. Thus, these results demonstrate that parafibromin is a nuclear protein. However, expression of the PL-A, PL-B and PL-C constructs (Figure 1 ) did not affect nuclear localization, thereby indicating that NLS BP-1 and NLS BP-3/MP-2 were unlikely to be of functional significance and that the functional NLS(s) was likely to be located between amino acids 92 and 388. Furthermore, similar studies of COS-7 cells transiently transfected with the EGFP-tagged mutant parafibromins Y55X (Tyr55Stop), K136X (Lys136Stop) and L64P, which have been reported in HPT-JT patients (Carpten et al., 2002) , revealed the truncated mutant Y55X and K136X parafibromins to be distributed in the nucleus and cytoplasm ( Figure 3) ; this distribution was similar to that observed with EGFP alone (Figure 2 ). The L64P mutant parafibromin retained nuclear localization. Moreover, the engineered mutant EGFP-tagged parafibromins R76A þ R77A and K393A þ K394A, which disrupt NLS BP-1 and NLS BP-3, respectively, also retained nuclear localization (Figure 3) . Collectively, these results confirm that NLS BP-1, NLS BP-3 and NLS MP-2 are non-functional and that the HPT-JT-associated truncated parafibromin mutations Y55X and K136X result in a loss of a functional NLS, which is likely to be either NLS BP-2 or NLS MP-1 (Figure 1 ).
The putative MP NLS at residues 136-139 (MP-1, Figure 1 ) could also form part of the BP NLS (residues 125 þ 126 and 136-139, BP-2), and mutant EGFPand cMyc-tagged parafibromin constructs involving the residues of each of these BP and MP NLSs of Figure 1) . However, the K125A þ R126A mutant parafibromin construct, which disrupts the two key positively charged basic residues on the N-terminal side of the BP NLS, retained nuclear localization (Figures 4 and 5), thereby demonstrating that the BP NLS BP-2 is non-functional. In contrast, the mutant parafibromin constructs harbouring mutations of the positively charged basic residues, K136A þ K137A þ R139A or K136A þ K137A, were found to have cytoplasmic and nuclear distributions that were similar to that observed with EGFP or cMyc alone (Figures 2, 4 and 5). A mutation of the non-basic residue proline (P138A) did not disrupt nuclear localization (Figure 4) . Thus, these results demonstrate that parafibromin has a functional MP NLS, that conforms to the motif KKXR (Hodel et al., 2001 ) and consists of the amino acids KKPR at residues 136-139. These results were confirmed in HEK293 cells (data not shown). Figure 1 . COS-7 cells that were transfected with EGFP alone or that were untransfected (UT) were used as controls. At 24 h post-transfection, cells were fixed and stained using propidium iodide to identify nuclei. Confocal fluorescence microscopy, using wavelengths of 488 and 543 nm, was performed to detect the EGFP (green) and propidium iodide (red) images, respectively. Nuclear localization was confirmed by merging the images and detection of yellow emission. The confocal images were obtained using identical conditions. Scale bar ¼ 20 mm. Figure 3 Alterations in the nuclear localization of parafibromin by the HPT-JT-associated mutations Tyr55Stop (Y55X) and Lys136Stop (K136X). COS-7 cells were transiently transfected with the mutant parafibromin constructs Y55X, K136X and L64P (Table 1) , which have been reported in HPT-JT patients, and the engineered parafibromin mutants R76A þ R77A and K393A þ K394A, which disrupt NLS BP-1, NLS BP-3 and NLS MP-2 (Figure 1 ). The confocal images were obtained as described in Figure 2 . Scale bar ¼ 20 mm.
Western blot analyses confirms nuclear localization of parafibromin and presence of a functional MP NLS at residues 136-139
The alterations in subcellular localization (Figures 4 and 5) that resulted from engineered mutants of the parafibromin MP NLS at residues 136-139 (MP-1, Figure 1 ) and the predicted BP NLS at residues 125-139 (BP-2, Figure 1 ) were confirmed by Western blot analyses (Figure 6 ) of the cytoplasmic and nuclear fractions obtained from COS-7 cells that had been transiently transfected with the appropriate EGFPparafibromin construct. WT parafibromin was detected predominantly in the nuclear fraction, thereby confirming its nuclear localization. In contrast, EGFP alone was detected predominantly in the cytoplasmic fraction but also in the nuclear fraction and this is consistent with the results obtained from confocal fluorescence microscopy ( Figure 2 ). The engineered parafibromin construct in which all five of the basic residues,
, were mutated was found to be present in the cytoplasmic and nuclear fractions, and this was similar to that observed with EGFP alone. This demonstrated that this domain of parafibromin contained a functional NLS. However, the K125A þ R126A mutant parafibromin was found predominantly in the nuclear fraction, and this was similar to that observed with the WT parafibromin. This confirmed that the BP NLS BP-2 (Figure 1 ) is non-functional and is consistent with the results of confocal fluorescence microscopy (Figures 4 and 5) . The Figure 4 Identification of a functional MP NLS, which consists of the amino acids KKPR at residues 136-139, using EGFPparafibromin constructs. Mutant EGFP-parafibromin constructs involving the amino acids of the putative MP NLS at residues 136-139 (MP-1, Figure 1 ) and the putative BP NLS (residues 125 þ 126 and 136-139, BP-2) were transiently transfected into COS-7 cells. Confocal images were obtained as described in Figure 2 , Scale bar ¼ 20 mm. Figure 5 Demonstration of a functional MP NLS, which consists of the amino acids KKPR at residues 136-139, using cMycparafibromin constructs. Full-length WT and mutant cMycparafibromin constructs involving the amino acids of the putative MP NLS at residues 136-139 (MP-1, Figure 1 ) and the putative BP NLS (residues 125 þ 126 and 136-139, BP-2) were transiently transfected into COS-7 cells. COS-7 cells that were transfected with pCMV-Myc alone or that were untransfected (data not shown) were used as controls. Confocal images were obtained as described in Figure 2 , using a mouse anti-cMyc primary antibody and a FITC-conjugated goat anti-mouse secondary antibody. Scale bar ¼ 20 mm.
parafibromins harbouring mutations of the basic residues, K136A þ K137A þ R139A or K136X, were found with a greater abundance in the cytoplasmic fraction, when compared to WT parafibromin. Mutation of the non-basic residue P138, did not disrupt nuclear localization, and this is consistent with its location as the third residue in the characteristic MP NLS motif K(K/R)X(K/R), where X can be any residue (Hodel et al., 2001) . Thus, these results, which confirm those obtained with confocal fluorescence microscopy ( Figures 4 and 5) , demonstrate that parafibromin has a functional MP NLS consisting of the amino acids KKPR at residues 136-139.
Discussion
Our results demonstrate that parafibromin is a nuclear protein with an evolutionarily conserved functional MP NLS, KKPR, at residues 136-139. The nuclear localization of parafibromin is in agreement with the results of three other studies (Tan et al., 2004; Hahn and Marsh, 2005; Rozenblatt-Rosen et al., 2005) . Parafibromin is a 61 kDa protein, and it has been reported that proteins with a molecular mass >45 kDa cannot diffuse freely across the nuclear envelope and require to be actively transported through the nuclear pore complex via a process that involves recognition by the importins of NLSs in the proteins (Quadrini and Bieker, 2002; Vandenbroucke et al., 2004) . Our results show that the translocation of parafibromin to the nuclear compartment involves a functional MP NLS at residues 136-139 (NLS MP-1, Figure 1 ). These findings are at variance with those of Hahn and Marsh (2005) , who reported that parafibromin has a functional BP NLS at residues 125-139 (NLS BP-2, Figure 1 ). The differences between the two studies are unlikely to be due to the use of different cell types as HEK293 cells were used in both studies, and our investigations yielded the same results in HEK293 and COS-7 cells. However, an examination of the data from the report by Hahn and Marsh (2005) reveals several inaccuracies and two that may account for the differences will be briefly reviewed. Firstly, Hahn and Marsh (2005) claim that the BP NLS at residues 125-139 (NLS BP-2, Figure 1 ) is evolutionarily conserved; however, the positively charged basic lysine (K) at codon 125 and arginine (R) at codon 126 of the NLS are not conserved in C. elegans (Figure 1c ). This lack of evolutionary conservation of the two critical basic residues at the N-terminus of NLS BP-2 indicates that this BP NLS is not functional in C. elegans. Secondly, Hahn and Marsh (2005) report that expression of an HPT-JT-associated mutation L136X (Leucine 136 Stop) resulted in 'both nuclear and cytoplasmic localization but with increased localization in the nucleus'; it is important to note that the naturally occurring residue at codon 136 of human parafibromin is lysine (K) and that the HPT-JT-associated mutation reported by Carpten et al. (2002) is K136X (Lys136Stop) (Figure 3) and not L136X as reported by Hahn and Marsh (2005) . This inaccuracy in the report by Hahn and Marsh (2005) renders interpretation of their data difficult. In contrast, our data conclusively demonstrate, by the two independent methods of confocal fluorescence microscopy (Figures 2-5, and Table 1 ) and Western blot analysis of subcellular fractions (Figure 6 ), that K136X results in a loss of nuclear localization of parafibromin. Furthermore, our results regarding the K136X mutant parafibromin are in agreement with those of RozenblattRosen et al. (2005) . Moreover, our data show that the engineered missense mutant, K125A þ R126A, retains nuclear localization (Figures 4-6 ), thereby further indicating that these basic amino acids at residues 125 and 126 are not part of a functional BP NLS. Indeed our data demonstrate that the basic amino acids of residues 136-139 form a functional MP NLS, as mutations of lysine residues, K136A þ K137A, alone, or in combination with the arginine residue, K136A þ K137A þ R139A, result in loss of nuclear localization. Given the inconsistencies in the report of Hahn and Marsh (2005) , it would seem that the interpretation that parafibromin has a functional BP NLS is incorrect. Instead, the conclusion that parafibromin has an evolutionarily conserved functional MP NLS is correct and supported by our data (Figures 1, 4-6 ). Results from 14 of the EGFP-tagged parafibromin constructs (13 mutant and one wild-type), the empty vector and the untransfected cells are shown. Similar results were obtained using HEK293 cells transfected with these EGFP-tagged parafibromin constructs, and also by using these parafibromin constructs tagged with cMyc and transiently transfected in COS-7 cells (data not shown).
b For each construct 50 transfected COS-7 cells were independently counted by two investigators (KJB and NYL), and the results represent the averages of the two counts. The two independent counts were highly concordant (r ¼ 0.88, Pp0.001).
c-f These four constructs also yielded cells that had only cytoplasmic staining and this was observed in 2, 2, 11 and 1% of cells, respectively.
Nuclear transport has been proven to be a fundamental and critical mechanism for regulating protein localization and the function of many tumour suppressors (Fabbro and Henderson, 2003) . With regard to this, it is interesting to note that B50% of the 27 different germline and 75% of the 22 different somatic HRPT2 mutations (Bradley et al., 2005 (Bradley et al., , 2006 result in a loss of the MP NLS at residues 136-139. Thus, a loss of NLS MP-1 (Figure 1 ) and an absence of parafibromin from the nucleus are likely to be important events in the aetiology of parathyroid tumours. Indeed, parafibromin and three other nuclear proteins, cyclin D1 (CCND1), retinoblastoma (RB) and menin, which is encoded by the multiple endocrine neoplasia type 1 (MEN1) gene (Table 2) , have important roles in the aetiology of parathyroid tumours and in cell cycle regulation (Baldin et al., 1993; Zacksenhaus et al., 1993; Hunter and Pines, 1994; Guru et al., 1998) . For example, cyclin D1 over-expression is found in 15% of sporadic, that is, non-familial parathyroid adenomas; RB loss occurs in 50-100% of parathyroid carcinomas and 10% of parathyroid adenomas, and menin loss is associated with all MEN1-associated parathyroid tumours, and 18% of non-MEN1 parathyroid tumours (Thakker and Juppner, 2006) . These proteins also have interacting roles in regulating the cell cycle that are of likely importance in controlling parathyroid cell proliferation. The tumour suppressor RB controls G1/S transition by modulating the activity of transcriptional factors such as E2F1, and the activity of RB itself is tightly regulated by Cytoplasmic (C) and nuclear (N) fractions obtained from COS-7 cells transiently transfected with constructs encoding EGFP-tagged WT or mutant parafibromin were analysed on Western blots. COS-7 cells that were transfected with pEGFP vector alone or that were untransfected (UT) were used as controls. An anti-EGFP antibody detected a B91 kDa band corresponding to EGFP-tagged (30 kDa) full-length parafibromin (61 kDa), and a band of B45 kDa for EGFP-parafibromin with the Lys136Stop (K136X) mutation. Western blots with anti-a-tubulin and anti-lamin antibodies confirmed that the procedure yielded nuclear and cytoplasmic fractions that were free from detectable amounts of cytoplasmic and nuclear proteins, respectively. cyclin-dependent kinase 4 (CDK4) and CDK6 which are activated by cyclin D1 (Zacksenhaus et al., 1993) . Furthermore, transient over-expression of parafibromin inhibits cyclin D1 expression whereas downregulation of parafibromin using small interfering RNA (siRNA) leads to premature entry of cells into S phase (Woodard et al., 2004; Yart et al., 2005) . In addition, parafibromin is associated with a Set-1-like histone methyltransferase (HMTase) complex that methylates H3 on lysine 4, and thereby initiates transcription by chromatin modification and activation of RNA polymerase II (Rozenblatt-Rosen et al., 2005; Yart et al., 2005) . Interestingly, the tumour suppressor menin has also been shown to be associated with a Set-1-like HMTase complex and RNA polymerase II, although it is important to note that menin and parafibromin have not been shown to have a direct interaction (RozenblattRosen et al., 2005) . This suggests that there are likely to be other nuclear proteins that are involved in forming these complexes that regulate genes that are involved in controlling parathyroid cell differentiation and proliferation. The future identification of these other nuclear proteins together with a characterization of their respective NLSs, in a manner similar to our study of parafibromin, will help in further elucidating their roles and that of parafibromin in parathyroid tumourigenesis.
Materials and methods

Database analysis for NLSs
The prediction programmes PROSITE (http://us. expasy.org/ prosite), PREDICT NLS online (http://cubic.bioc.columbia. edu/predictNLS) and PSORT II (http://psort.hgc.jp) were used to identify putative NLSs. Alignment of parafibromin sequences in different species was carried out using the protein-protein Basic Local Alignment Search Tool algorithm from National Centre for Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov/). The accession numbers for the sequences from H. sapiens, M. musculus, R. norvegicus, X. tropicalis, D.rerio, D. melanogaster and C. elegans are, NP_078805, NP_666103, NP_001019940, NP_001016031, NP_956642, NP_649863 and NP_500465, respectively.
Expression constructs
The WT HRPT2 expression vector was constructed by polymerase chain reaction (PCR) amplification of HRPT2 cDNA (IMAGE clone 6170851) utilizing the oligonucleotide primers 5 0 -ttcgaattcatggcggacgtgcttagcgtcc-3 0 (forward) and 5 0 -taccgtcgacataattcagaatctcaagtgc-3 0 (reverse), and cloning into pGEM-T (Promega, WI, USA). This was subcloned into the mammalian expression vectors pEGFP-C2 (Clontech, CA, USA) or pCMV-Myc (Clontech, CA, USA) using a shuttle vector pGBKT7 (Clontech, CA, USA), to yield parafibromin tagged at the N-terminus with EGFP or cMyc, respectively. The three PL constructs (PL-A, -B and -C, Figure 1a) were generated by the use of appropriate primers to introduce EcoRI and SalI restriction endonuclease sites in the full-lengthtagged WT construct. Mutations were introduced by use of site-directed mutagenesis (Quikchange, Stratagene, CA, USA) (Kennedy et al., 2005) . The DNA sequences of all constructs were verified using a semi-automated detection system (ABI 377 sequencer; PE Applied Biosystems, CA, USA), as described previously (Nesbit et al., 2004) .
Confocal fluorescence microscopy COS-7 or HEK293 cells were cultured on glass coverslips to 50-60% confluency, and transiently transfected with 0.4 mg. DNA of an expression construct using FuGENE 6 (Roche, Basel, Switzerland). Twenty-four hours post-transfection, the cells were washed with phosphate-buffered saline (PBS), fixed in 4% paraformaldehyde, permeabilized using Triton X-100 (0.5% v/v) containing RNaseA (100 mg/ml), stained with propidium iodide (3 mg/ml) (Sigma, MO, USA) and mounted with Vectashield (Vector Laboratories, CA, USA). In addition, cells transfected with the cMyc constructs were blocked with 10% goat serum, and incubated with primary mouse monoclonal anti-cMyc (9E10 Santa Cruz Biotechnology, CA, USA) and secondary fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse antibodies (all at dilutions of 1:100). The subcellular localizations of the fusion proteins were visualized using a Biorad Radiance 2100 confocal microscope with a X60 objective. Confocal images were recorded under identical conditions. Excitation was performed with a 488 nm Argon (for EGFP and cMyc) and a 543 nm HeNe (for PI) laser and filtered accordingly.
Western blot analyses of subcellular fractions COS-7 or HEK293 cells were cultured and transfected with approximately 1 mg DNA of the expression construct. Cells were harvested, once 100% confluent, 48 h after transfection using an enzyme free cell dissociation buffer (Invitrogen Corporation, CA, USA) and washed in PBS. Nuclear and cytoplasmic fractionation was then performed using chemical cell membrane disruption (NE-PER Kit, Pierce Biotechnology, IL, USA) with additional centrifugation steps to remove nuclear material from the cytoplasmic fraction and additional washes using PBS to minimize cytoplasmic contamination of the nuclear fraction. The protein content of the lysates was quantified (Micro BCA Protein Assay Reagent Kit, Pierce Biotechnology, IL, USA) and 20 mg of protein was separated on a 10% sodium dodecylsulfate-polyacrylamide gel, and electrotransferred to a nitrocellulose membrane. Western blot analysis was performed with appropriate antibodies (all at one in 500 dilutions); lamin A/C (Santa Cruz Biotechnology, CA, USA) and a-tubulin antibodies (Santa Cruz Biotechnology, CA, USA) were used to confirm the nuclear and cytoplasmic fractions, respectively, and an EGFP antibody was utilized to detect the tagged parafibromin constructs. An appropriate secondary antibody was used and detected by utilizing an enhanced chemiluminescence Western blotting detection kit (Amersham International, NJ, USA) (Kennedy et al., 2005) . The secondary antibodies were horesradish peroxidase-conjugated (HRP) donkey anti-goat (Santa Cruz Biotechnology, CA, USA) for lamin at a dilution of one in 5000, and HRP-conjugated goat anti-mouse (Bio-Rad Laboratories, CA, USA) for a-tubulin and EGFP at dilutions of one in 6000.
